Le Lézard

News by subject: Clinical Study

1 2 3

27 july 2022

08:00
LexaGene Holdings, Inc.,  ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based syndromic testing in veterinary clinics, provides a brief summary of preliminary data...


21 july 2022

07:30
Field Trip Health Ltd. ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies, announced today the first successful dosings in the Phase 1 Clinical Study entitled "A Double-Blind, Randomized,...


20 july 2022

16:10
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that while its partner, Assembly...

08:00
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market...


15 july 2022

17:05
Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, has today published its financial results for the quarter ended May 31, 2022. A full...


12 july 2022

08:45
Cannabix Technologies Inc. (the "Company or Cannabix") developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company is participating in a new comprehensive multi-analysis study of subjects under the...


7 july 2022

07:00
Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its planned Phase 1 clinical human study of AP-188 ("N,N-dimethyltryptamine" or "DMT")....


6 july 2022

07:15
Zenith Epigenetics Ltd. ("Zenith" or the "Company") announced today that its leading BET inhibitor, ZEN-3694, is being evaluated in seven NCI sponsored clinical trials for safety and efficacy in multiple oncology indications with significant unmet...


5 july 2022

08:00
C-POLARtm Technologies Inc., a bioprotection company dedicated to setting the new standard of health and safety through the protection against viruses and microorganisms, today announced positive results from independent studies of C-POLARtm's...


29 june 2022

08:00
Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it has initiated screening of subjects for the...


25 june 2022

04:05
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients 50% (16 out of 32) of patients maintained HBsAg levels below 100 IU/mL 24 weeks after their last AB-729 dose In the first five patients...


24 june 2022

11:45
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's U.S. Food & Drug...


21 june 2022

07:15
Zenith Epigenetics Ltd. ("Zenith" or the "Company") announced today that the data from its Phase 2 Metastatic Triple Negative Breast Cancer (mTNBC) clinical trial combining ZEN-3694 + Pfizer Inc.'s Talzenna (talazoparib) was highlighted at an oral...

07:00
Xenon...


17 june 2022

07:30
Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and...

07:00
Mydecine Innovations Group (NEO: MYCO) ("Mydecine" or the "Company"), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced that the U.S. Food and Drug Administration (FDA) has cleared MYCO-001...


16 june 2022

07:30
Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and...


9 june 2022

14:00
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT) included a more diverse...

03:05
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed five...


7 june 2022

07:00
PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a leader in specialty...


6 june 2022

20:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and...

13:55
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's U.S. Food & Drug...


3 june 2022

08:00
Biogen Inc.  and Bio-Thera Solutions, Ltd. (688177.SH) today presented positive Phase 3 data for BIIB800 (BAT1806), a biosimilar candidate referencing ACTEMRA®/ROACTEMRA® (tocilizumab), anti-interleukin-6 receptor monoclonal antibody, at the Annual...

05:20
Biogen Inc. ...


2 june 2022

07:00
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that treatment with...


1 june 2022

07:00
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...


31 may 2022

07:00
ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), the Plant-Based baby, toddler, and children nutrition company, is pleased to announce that it has concluded a second successful preclinical study on its Plant-Based infant...


26 may 2022

10:20
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's U.S. Food & Drug...


25 may 2022

07:30
With housing taking centre stage in the lead up to next week's provincial election, it's clear that voters are looking for a provincial government that will take action on addressing the housing crisis and bring affordability closer within reach. But...


24 may 2022

23:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the...


19 may 2022

09:05
? Based on clinical data from previously completed B-SIMPLE4 pivotal Phase 3 clinical study, berdazimer gel, 10.3% (SB206) can shorten the duration of molluscum infection and increase the chance of clearance by enhancing inflammation of molluscum ?...

03:05
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that its iUGO Care...


18 may 2022

07:30
Acasti Pharma Inc. ("Acasti" or the "Company") announced today that the top line results of its pharmacokinetic...


16 may 2022

10:50
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's U.S. Food & Drug...


12 may 2022

07:15
Mindset Pharma Inc. ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs,...


11 may 2022

09:05
Rakovina Therapeutics Inc. ("the Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce the presentation of new data during the 2022 AACR...


10 may 2022

08:15
Zenith Epigenetics Ltd. ("Zenith" or the "Company") announced today the initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) clinical trial combining ZEN-3694 + Pfizer Inc.'s Talzenna (talazoparib). The trial will continue to evaluate the...

07:30
Theratechnologies Inc. ("Theratechnologies" or "the Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today initiated enrollment of patients in the basket portion of the...


5 may 2022

07:30
Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an...


4 may 2022

07:30
Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that the U.S. Food and Drug Administration...

07:00
Starton Therapeutics Inc., a clinical stage biotechnology company provides updates on its first-in-human Phase 1 STAR-LLD clinical trial of its investigational continuous delivery...


2 may 2022

08:05
-- Levels of Ki67+ expression by CD8+ T cells and NK cells increased by 17-fold and 10-fold, respectively, in the third cohort (30 µg/kg dose) when compared to baseline -- NK cell / Treg and CD8+T cell / Treg ratios increased by 4.4-fold and 2.6...


30 april 2022

04:00
The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes.The study population ? 440 adults and children 6 years and older with type 1 diabetes ? was more...


25 april 2022

16:45
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's U.S. Food & Drug...


14 april 2022

06:00
Rakovina Therapeutics Inc. , a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, presented at the American Association of Cancer Research Annual Meeting. A Media Snippet...


8 april 2022

20:30
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. ("Coherus") announced the results of the prespecified final progression-free survival ("PFS") analysis and the interim overall survival...


2 april 2022

08:55
Core One Labs Inc. , , (the "Company" or "Core One") is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. ("Akome") through a research arrangement with Neuro-Zone Srl, ("Neuro-Zone") based in Bresso, Italy, has achieved...


30 march 2022

07:30
Biogen Inc.  has submitted the final study protocol for the confirmatory Phase 4 ENVISION trial to the U.S. Food and Drug Administration (FDA) for review and approval. This is in line with the company's...


24 march 2022

15:45
Opticyte® Amniotic Ocular Matrix, a product of Research Triangle Park-based Merakris Therapeutics, has gotten the attention of a leading trade publication directed at optometrists. The innovative eye care therapy creates a biological barrier to...


23 march 2022

07:00
100% of patients treated with ketamine demonstrated reduction in dyskinesias as measured by the Unified Dyskinesia Rating Scale Ketamine was well tolerated with no serious adverse events reported Study results are adequate to give an effect...

1 2 3